Company Profile
MPA Technical Devices Srl is an Italian company specializing in designing and manufacturing top quality and accurate dosing systems.
We achieve the highest standards of precision for dosing all kinds of pharmaceutical substances thanks to over 20 years of experience, a technologically advanced workshop and constant innovation in design. We aim for tailored solutions designed to meet our customers needs and requirements.
Engineering & Design
A highly skilled team of designers can develop customized projects starting from the specifications of the pharmaceutical machine or from the characteristics of the liquids to be dosed. We ensure customer-focused advice, we analyse each problem and propose customized solutions to optimise the performance of the entire production line. It is also possible to re-design or to improve parts or existing systems, to achieve the best results based on users’ feedbacks. The final products are complete with surface treatments as well as special coatings. Components are laser marked on customer request. MPA Technical Devices offers a comprehensive service, support and technical advice from design to final installation.
Company Philosophy
Our goal is to ensure long service life and perfection in every one of our products.
We aim for the highest levels of dosing accuracy and precision since we strongly believe that details lead to perfection in terms of quality and reliability.
“Details make perfection, and perfection is not a detail.” – Leonardo da Vinci
Quality & Traceability
MPA Technical Devices has always used Food&Pharma regulations compliant material coming from European steelworks and manufacturers MOCA or FDA certified, ensuring maximum quality of products thanks to strict controls on raw materials.
On delivery, we check and cross reference each raw material bar to the corresponding certificate number. When the material is cut, the certificate number is linked to the workpiece, achieving in this way a real traceability for each component of our products.
The final product must meet the highest quality standards monitored with appropriate measuring equipment. Products certifications include the tests reports carried out.
Scanning an optional QR code on the product, our customers can have immediate access from their tablet or smartphone to the 3.1 certificates, special coatings, treatments, quality and roughness reports.
We consider quality and transparency of primary importance: for this reason, we regularly test the materials and coatings of our products in independent and ISO certified laboratories, making the reports available to our customers.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...